Myelodysplastic-Myeloproliferative Diseases
64
2
3
51
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
12 trials with published results (19%)
Research Maturity
51 completed trials (80% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.5%
8 terminated out of 64 trials
86.4%
-0.1% vs benchmark
3%
2 trials in Phase 3/4
24%
12 of 51 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 51 completed trials
Clinical Trials (64)
Clonal Hematopoiesis of Immunological Significance
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation
Italian Network MDS Registry
Myeloproliferative Neoplasms (MPNs) Patient Registry
Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder
Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer